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To respond to the NIH’s policy for rigor and reproducibility in preclinical research, many
journals have implemented guidelines and checklists to guide authors in improving
the rigor and reproducibility of their research. Transparency in developing detailed
prospective experimental designs and providing raw data are essential premises of rigor
and reproducibility. Standard peer reviews and journal-specific technical and statistical
reviews are critical factors for enhancing rigor and reproducibility. This brief review
also shares some experience from Arteriosclerosis, Thrombosis, and Vascular Biology,
an American Heart Association journal, that has implemented several mechanisms to
enhance rigor and reproducibility for preclinical research.
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INTRODUCTION
In the past 50 years, the number of scientific publications has grown from ∼300 K per year to
above 1,000 K every year. During this interval publication, retractions have also increased rapidly.
Retractions cover a spectrum of causes including errors, misconduct, fabrication, or fraud. These
are well-publicized examples that hinder reproductivity. However, a broader and more insidious
problem is inability to reproduce. One illustration is a survey published in Nature that found
only six (11%) of 53 selected publications from academic laboratories being reproduced by a
pharmaceutical company, raising serious concerns on rigor and reproducibility (1). The survey
concluded that the studies they were able to reproduce were characterized by authors being
attentive to controls, reagents, investigator bias, and describing complete datasets. In contrast,
for results that could not be reproduced, limited methodological information was provided, and
experiments were not rigorously performed or selected with bias.
In 2012, the United States National Institute of Neurological Disorders and Stroke convened
a meeting to develop recommendations for improving preclinical research (2). This initial
call for transparent reporting prompted subsequent discussion and implementation of rigorous
experimental design. In 2014, the National Institutes of Health (NIH) held a joint workshop with
the Nature Publishing Group and Science to discuss issues related to rigor and reproducibility
of research articles. Subsequently, in 2016, the NIH announced a Rigor and Reproducibility
policy and guidelines for scientific research, including transparency in reporting detailed
methods and rigorous statistical analyses. The NIH has also provided a resource chart
(https://grants.nih.gov/grants/RigorandReproducibilityChart508.pdf) to emphasize four areas of
focus for grant applications:
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1. Scientific premise (the rigor of previous experimental design
and data analysis).
2. Scientific rigor for experimental design of the
proposed research.
3. Biological variables (particularly sex).
4. Authentication of key biological and/or chemical resources.

2. Level 2 requires that data must be posted to a trusted
repository, while exceptions must be identified at
manuscript submission.
3. Level 3 requires that reported analyses must be reproduced
independently by a third party, in addition to the request
in Level 2.

In response to the NIH’s policy and guidelines, many journals
have implemented multiple guidelines and certain checklists
for manuscript submission. Arteriosclerosis, Thrombosis, and
Vascular Biology (ATVB), an American Heart Association (AHA)
journal, is a well-recognized cardiovascular research journal that
receives ∼1,500 manuscripts every year. We will use ATVB as
an example when we discuss some parts, especially the technical
review section, in this mini review.

Most scientific journals, including ATVB, require the
transparency of Level 1, to state the availability of data in
manuscripts. More recently, many journals are taking efforts
toward Level 2, especially for large datasets such as bulk RNA
sequencing data, single cell transcriptomics data, and proteomics
data. Gene Expression Omnibus (GEO) and European
Nucleotide Archive (ENA) have been used as appropriate
and trusted repositories for nucleotide transcriptomics, and the
ProteomeXchange Consortium developed through PRIDE is
for mass-spectrometry-based proteomics repository. bioRxiv,
hosted by the Cold Spring Harbor Laboratory, is a popular
open-access preprint repository for biological sciences. The NIH
and some journals encourage authors to post their manuscripts
with detailed methods and raw data for preclinical research in
bioRxiv prior to submission. To facilitate manuscript submission
to a journal, direct submissions are available from bioRxiv to
an increasing number of journals. Attributed to the enhanced
reputation of bioRxiv, medRxiv was launched in 2019 as an
open-access preprint repository for clinical and populational
research. Although bioRxiv and medRxiv post original research
without peer review process, they are read and commented by
more researchers who are interested in the Research Topics.
The dialog established by this open forum system has been
considered to be a more rigorous “review process” that offers
opportunities for authors to correct apparent errors prior to its
publishing in a journal.
For animal research, the Animal Research: Reporting
of in vivo Experiments (ARRIVE) guidelines published in
2010 (3) has become a “gold” standard for many journals.
Recently, the ARRIVE guidelines 2.0 (4) introduced ARRIVE
Essential 10 as the basic minimum for manuscript submission.
These include minimal recommendations for study design,
prospective estimation of sample size, inclusion and exclusion
criteria, randomization, blinding, outcome measures, statistical
methods, detailed information of experimental animals, detailed
experimental procedures, and result description. ATVB has been
implementing Major Resources Table (https://www.ahajournals.
org/atvb/manuscript-preparation) since 2017 that includes
animal information (source, background strain, and sex), mouse
breeding strategy, antibody information (source catalog number,
batch number, and working concentration), and other necessary
reagents. AHA journals are in the process of including ARRIVE
Essential 10 in Major Resources Table.
The Advisory Committee to the Director (ACD) of the
NIH working group on enhancing rigor, transparency, and
translatability in animal research presented a report (https://
www.acd.od.nih.gov/working-groups/eprar.html) in June 2021.
The ACD working group recommends that the NIH should
have detailed plans to identify gaps and opportunities and
train animal researchers for appropriate experimental design

IMPLEMENTATION OF PRINCIPLES AND
GUIDELINES IS NECESSARY TO IMPROVE
TRANSPARENCY, RIGOR, AND
REPRODUCIBILITY
Multiple guidelines have been launched for appropriate study
design and data analysis as well as transparent reporting of
animal research (Table 1). One important guideline is the
Transparency and Openness Promotion (TOP) guidelines. The
TOP guidelines provide a category of “not implemented” for
journals that have no declared policy for sharing experimental
details. For journals that require a declaration, the guidelines
provide three levels for data transparency:
1. Level 1 requires that authors disclose whether data are
available and, if so, where to access them.

TABLE 1 | Selected major guidelines for transparent reporting.
Abbreviation Full name

Scope

ARRIVE

Animal research:
reporting of in vivo
experiments

Checklist of
References (3, 4)
recommendations to
improve the reporting
of animal research

MIAME

Minimum information
about a microarray
experiment

Checklist for
microarray studies

https://www.ncbi.
nlm.nih.gov/geo/
info/MIAME.html

MINSEQE

Minimum information
about a
next-generation
sequencing
experiment

Checklist for
sequencing studies

https://www.ncbi.
nlm.nih.gov/geo/
info/MIAME.html

NIH

National Institutes of
Health

Policies and
guidelines for
preclinical and clinical
research

https://grants.nih.
gov/policy/
reproducibility/
index.htm

TOP

Transparency and
openness promotion

Journal publishing
standards for
transparency and
data sharing

https://www.cos.
io/initiatives/topguidelines
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own previous publications. Therefore, automated flagging of
plagiarism, based on automated analysis, usually needs extensive
manual verification.
Although the peer review process has flaws, it is a powerful
tool to improve the quality of research manuscripts and deliver
meaningful science to the scientific community. To minimize
potentially biased comments, journal editors need to determine
who are the most appropriate, qualified reviewers. It is not
uncommon that the three reviewers have different opinions on
a manuscript. In this case, editors also need to balance the
comments based on the journal policies and their knowledge
on the research. Therefore, journal editors are the driving factor
for appropriate peer review process. For ATVB, the editors
have developed a large, stable, and reliable reviewer network.
They evaluate whether reviewers provide their comments on a
timely manner with unbiased and constructive opinions. Also,
for highly conflicted comments among the three reviewers, the
handling editor can invite additional members of the editorial
team to contribute to an online discussion forum prior to making
a decision.

and statistical analyses. The ACD working group also suggested
an enhanced implementation of prospective registration for
animal studies in a similar process as clinical trials. This process
can be performed on an existing online animal study registry
(https://www.animalstudyregistry.org/asr_web/index.action). It
is likely that this will have increased emphasis in the
near future.
Overall, Level 1 and Level 2 of the TOP guidelines for
transparency are recommended for manuscript submission.
ARRIVE guidelines, minimally Essential 10, should be
implemented for designing animal studies prospectively
and for reporting outcomes of animal research.

PEER REVIEW IS NEEDED FOR
PUBLISHING AND ADVANCING
SCIENTIFIC RESEARCH
Peer review is a process in scientific journals to evaluate
manuscripts of original research by experts in the same or similar
field. Peer review critiques the significance and originality of a
publication and provides suggestions to help authors improve
quality, including identifying conceptual and technical errors
that may impact data interpretation. Therefore, peer review is
a fundamental process to assess quality, impact, and novelty
of the science reported in a manuscript before it is published
(5). Although peer review may be time-consuming, it could be
mutually beneficial, because reviewers may be inspired by the
manuscript to advance their own research. Despite its many
benefits, some deficiencies of peer review have been noted.
In most journals, peer review is usually performed by two
to three experts who are selected based on their expertise in
the same subject matter as the submission. These are selected
by an editor who preferably has knowledge of the subject area
of the manuscript. The most common process is “single-blind”
review; namely, the reviewers know the identity of the authors,
but the authors are not informed of the identity of the reviewers.
It is not infrequent that authors complain that peer review is
neither fair nor constructive. In particular, if the authors’ findings
conflict with a reviewer’s own research, it may lead to biased
critiques. To overcome this potential deficiency of peer review,
most journals suggest that authors provide names to exclude as a
reviewer, mainly those who may have conflicts of interest. Many
journals allow to exclusion of up to three potential reviewers
by providing a reason for excluding the specific reviewers.
Some journals provide the option post acceptance notification
of reviewers’ names and a link to their critiques. Some journals
have implemented a double-blind process in which the reviewers
are not provided with the identity of the authors, and vice versa.
However, given the proclivity of citing previous publications,
blinding of the authors’ identity to the reviewers has challenges.
Another apparent deficiency of peer review is that it does
not provide a systemic evaluation of plagiarism. Some journals
have implemented some software tools to screen for plagiarism.
The caveats of plagiarism software detection need to be
considered. For example, it is common, and acceptable, to
provide a description of methods that replicates the authors’
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TECHNICAL REVIEW PROVIDES
CONSISTENT STANDARD FOR
ENHANCING RIGOR AND
REPRODUCIBILITY
Historically, some journals, especially those publishing clinical
and populational research, have statistical reviewers given
the complexity relative to classical preclinical research (6).
While concerns have been noted previously (7), statistical
analysis-related impact has had more limited attention for
preclinical research until the NIH launched its policies and
guidelines. The present editors of ATVB have endeavored
to improve manuscript quality and consistency. The initial
steps included asking reviewers to fill a detailed checklist of
their evaluation regarding the authentication of experimental
design and statistical analysis. Unfortunately, this approach did
not provide consistent evaluations. Indeed, the same question
on authentication for a same manuscript could receive three
different answers from the three reviewers. This is particularly
critical when the question involves statistical analysis methods
and appropriateness. Although the editors have continuously
expanded the details of the technical guidelines for manuscript
submission and peer review process, improvement in appropriate
statistical analysis and methodology has been modest. In 2017,
ATVB decided to appoint a technical review editor to provide
a process for consistent evaluation of statistical analysis and
methodology. This was applied to all original manuscripts
receiving an editorial decision that permitted resubmission. This
process has profoundly enhanced the transparency of methods,
consistency and accuracy of statistical analysis methods, and
rigor of experiments and biological replicates, and it considers sex
as a biological variable. Significant improvement of publications
in ATVB attributed to this technical review process has also
prompted implementation of technical review editors in several
other AHA journals.
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“Graph Pad Prism version 9.1.0.” We hope that this can help
authors understand how to describe and perform a statistical
analysis appropriately.

The most common deficiencies of manuscripts submitted
to ATVB that have been illuminated by the technical review
process include:
1. Statistical analyses: conducting parametric tests without
stating that datasets fit the constraints of variance and
normality, and not conducting appropriate multigroup tests.
2. Small sample size such as 3 biological replicates per group.

PERSPECTIVE
Researchers publish medical scientific articles to promote
academic career, advance medical science, and, ultimately,
improve human health. One example that achieves these
objectives is an article that was published in 2012 by Dr.
Doudna and Dr. Charpentier in Science that has impacted
science profoundly and the major premise has been reproduced
by many researchers (9). Meanwhile, there is anecdotal
acknowledgment that a substantial number of published studies
cannot be reproduced by other researchers. We have discussed
the key components for enhancing transparency, rigor, and
reproducibility that rely on policies, guidelines, journal editors,
peer review, and journal technical review. Unfortunately, these
policies and guidelines and strict rules by journals cannot
completely eliminate errors and misconduct. Investigators are
the determining factor for preventing errors and misconduct
in scientific research. To provide meaningful and replicable
science to the research community, we suggest that investigators
develop laboratory-specific standard operating procedures to
ensure transparency, rigor, and reproducibility within the team
and outside the team.
As excellently stated by Dr. Nallamothu, the editor-in-chief of
Circulation: Cardiovascular Quality and Outcomes, in a recent
editorial, “Very few answers in science are clear-cut or simple.
Most depend on the critical assumptions we make as part of an
iterative process in research. It is time to make those choices clear
for others to see, assess, debate, replicate, and build upon” (10).
Transparency is the key to build rigor and reproducibility, the
key to collaborate in research community, and the key to improve
scientific knowledge and discover new molecular mechanisms to
advance human health. We expect that the NIH and scientific
journals will enhance the present policies and guidelines with
ultimate goals to turn scientific discoveries from animal research
into preventing and treating human diseases.

To overcome the major issues noted, recently ATVB has included
a new checklist for manuscript submission. This is also the
checklist for technical review of ATVB (https://www.ahajournals.
org/atvb/manuscript-preparation). Below, we summarize the
checklist that focuses on appropriate statistical analysis:
1. Emphasize biological vs. technical replicates. Authors should
clearly state how many independent samples per group
(biological replicates) in each cohort were studied.
2. Data presentation should always show individual data for
each figure. Additionally, it is suggested that data tested by
parametric tests should be represented as mean and standard
error of mean (SEM) or standard deviation (SD), whereas
data tested by non-parametric tests should be represented as
median with confidence limits.
3. Statistical analysis: data should be tested for both normality
and equal variance as a pre-condition or justification for
conducting parametric analysis.
4. For sample size N ≤ 5 per group, it is recommended either
to perform a non-parametric statistical test or to increase
sample size. This is because normal distribution and data
homogeneity cannot be determined appropriately for small
sample sizes.
5. Precise P values, rather than P < 0.05 or not significant (NS),
should be provided.
6. Emphasize sex as a biological variable. Groups stratified by sex
should be analyzed separately.
We also provide an excellent description of a statistical analysis
that was published by Schneckmann et al. (8). This example
states, “Sample size estimation was based on previous results in
comparable studies, assuming 80% power at a significance level
of 0.05. Specific details on how many independent biological
samples or mice were included in an experiment or how many
times experiments were repeated independently are given in the
corresponding figure legends. Sample size is given in the figure
legends and data are presented as mean±SEM. For continuous
variables, normality and homogeneity of variance were assessed
by Shapiro-Wilk and Brown-Forsythe tests, respectively. After
confirming homogeneous variances and normality, two-group
comparisons for means were performed by two-sided unpaired
Student’s t test. In case of inhomogeneous variances, MannWhitney U test was performed. Multi-group comparisons for
means were performed by two-way ANOVA with Sidak multiple
comparison test. P<0.05 was considered statistically significant.
Statistical analyses mentioned above were performed using
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